Quantcast
Channel: mesotheliome.org
Viewing all articles
Browse latest Browse all 118

Penn Medicine: Immunotherapy drug pembrolizumab shows promise for mesothelioma patients

$
0
0

PD-1 inhibitor is safe, shrank tumors or stabilized disease in most patientsThe PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of…

Powered by WPeMatico


Viewing all articles
Browse latest Browse all 118

Trending Articles